The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Health-Economic Consequences of Diabetic Foot Lesions
Open accessAbstract
Diabetic foot complications result in huge costs for both society and the individual patients. Few reports on the health-economic consequences of diabetic foot infections have been published. In studies considering a wide societal perspective, costs of antibiotics were relatively low, whereas total costs for topical treatment were high relative to the total costs of foot infections. Total direct costs for healing of infected ulcers not requiring amputation are approximately 17,500 dollars (in 1998 US dollars), whereas the costs for lower-extremity amputations are approximately 30,000 dollars-33,500 dollars depending on the level of amputation. Prevention of foot ulcers and amputations by various methods, including patient education, proper footwear, and foot care, in patients at risk is cost effective or even cost saving. Awareness of the potential influence of reimbursement systems on prevention, management, and outcomes of diabetic foot lesions has increased. Despite methodological obstacles, modeling studies are needed in future health-economic evaluations to determine the cost effectiveness of various strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathways to Diabetic Limb Amputation: Basis for Prevention
Pecoraro, R. E., Reiber, G. E., & Burgess, E. M. (1990) · Diabetes Care · doi:10.2337/diacare.13.5.513 · Cited by 1,580
Incidence, outcomes, and cost of foot ulcers in patients with diabetes.
Ramsey, S. D., Newton, K., Blough, D., McCulloch, D. K., Sandhu, N., Reiber, G. E., & Wagner, E. H. (1999) · Diabetes Care · doi:10.2337/diacare.22.3.382 · Cited by 1,062
Lower-Extremity Amputation in People With Diabetes: Epidemiology and Prevention
Bild, D. E., Selby, J. V., Sinnock, P., Browner, W. S., Braveman, P., & Showstack, J. A. (1989) · Diabetes Care · doi:10.2337/diacare.12.1.24 · Cited by 523
American Diabetes Association (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1354 · Cited by 495
Miettinen, H., Lehto, S., Saikku, P., Haffner, S. M., Ronnemaa, T., Pyorala, K., & Laakso, M. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014934 · Cited by 447
What is the most effective way to reduce incidence of amputation in the diabetic foot?
Apelqvist, J., & Larsson, J. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200009/10)16:1+<::aid-dmrr139>3.0.co;2-8 · Cited by 408
Self-citationHealing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis
Margolis, D. J., Kantor, J., & Berlin, J. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.692 · Cited by 356
Larsson, J., Stenström, A., Apelqvist, J., & Agardh, C. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb02078.x · Cited by 341
Self-citationPotential Economic Benefits of Lower-Extremity Amputation Prevention Strategies in Diabetes
Ollendorf, D. A., Kotsanos, J. G., Wishner, W. J., Friedman, M., Cooper, T., Bittoni, M., & Oster, G. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1240 · Cited by 307
APELQVIST, J., RAGNARSON‐TENNVALL, G., LARSSON, J., & PERSSON, U. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01104.x · Cited by 305
Self-citationA cost analysis of diabetic lower-extremity ulcers.
Harrington, C., Zagari, M. J., Corea, J., & Klitenic, J. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1333 · Cited by 242
Ragnarson Tennvall, G., & Apelqvist, J. (2001) · Diabetologia · doi:10.1007/s001250100013 · Cited by 229
Self-citationCosts and duration of care for lower extremity ulcers in patients with diabetes
Sedory Holzer, S. E., Camerota, A., Martens, L., Cuerdon, T., Crystal-Peters, J., & Zagari, M. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80044-1 · Cited by 225
Foot Infections in Diabetic Patients: Decision and Cost-effectiveness Analyses
Eckman, M. H. (1995) · JAMA · doi:10.1001/jama.1995.03520330042035 · Cited by 221
Evaluation of a diabetic foot screening and protection programme
McCabe, C. J., Stevenson, R. C., & Dolan, A. M. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199801)15:1<80::aid-dia517>3.0.co;2-k · Cited by 208
Long-Term Costs for Foot Ulcers in Diabetic Patients in a Multidisciplinary Setting
Apelqvist, J., Ragnarson-Tennvall, G., Larsson, J., & Persson, U. (1995) · Foot & Ankle International · doi:10.1177/107110079501600702 · Cited by 205
Self-citationA systematic review of foot ulcer in patients with Type 2 diabetes mellitus. I: prevention
Mason, J., O’Keeffe, C., McIntosh, A., Hutchinson, A., Booth, A., & Young, R. J. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00133.x · Cited by 203
Factors contributing to the presentation of diabetic foot ulcers
Macfarlane, R. M., & Jeffcoate, W. J. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199710)14:10<867::aid-dia475>3.0.co;2-l · Cited by 183
Costs of Deep Foot Infections in Patients with Diabetes Mellitus
Tennvall, G. R., Apelqvist, J., & Eneroth, M. (2000) · PharmacoEconomics · doi:10.2165/00019053-200018030-00003 · Cited by 147
Self-citationThe Effects of Treatment on the Direct Costs of Diabetes
Herman, W. H., & Eastman, R. C. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.c19 · Cited by 138
International Consensus on the Diabetic Foot
Newrick, P. G. (2000) · BMJ · doi:10.1136/bmj.321.7261.642/a · Cited by 132
Health Economics: An Introduction to Economic EvaluationPreprint
Kobelt, G. (2002) · RePEc: Research Papers in Economics · Cited by 127
Patout, C. A., Birke, J. A., Horswell, R., Williams, D. M., & Cerise, F. P. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1339 · Cited by 120
The cost-effectiveness of different management strategies for Type I diabetes: a Swiss perspective
Palmer, A. J., Weiss, C., Sendi, P., Neeser, K., Brandt, A., Singh, G., Wenzel, H., & Spinas, G. A. (2000) · Diabetologia · doi:10.1007/s001250050003 · Cited by 116
Using Healthcare Claims Data for Outcomes Research and Pharmacoeconomic Analyses
Birnbaum, H. G., Crémieux, P., Greenberg, P. E., LeLorier, J., Ostrander, J., & Venditti, L. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916010-00001 · Cited by 109
Improved Quality of Diabetic Foot Care, 1984 vs 1990
Gibbons, G. W. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420170112017 · Cited by 101
Outcomes of preventative care in a diabetic foot specialty clinic
Armstrong, D. G., & Harkless, L. B. (1998) · The Journal of Foot & Ankle Surgery · doi:10.1016/s1067-2516(98)80022-7 · Cited by 100
The Diabetic Foot: Consequences of Delayed Treatment and Referral
Mills, J. L., Beckett, W. C., & Taylor, S. M. (1991) · Southern Medical Journal · doi:10.1097/00007611-199108000-00009 · Cited by 85
Apelqvist, J., & Ragnarson, T. (1996) · Acta Dermato Venereologica · doi:10.2340/0001555576231235 · Cited by 82
Self-citationSurgery for limb threatening ischaemia: A reappraisal of the costs and benefits
Johnson, B. F., Evans, L., Drury, R. B., Datta, D., Morris-Jones, W., & Beard, J. D. (1995) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/s1078-5884(05)80088-7 · Cited by 76
The effects of peripheral vascular disease with osteomyelitis in the diabetic foot
Hill, S. L., Holtzman, G. I., & Buse, R. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00050-1 · Cited by 69
International consensus on the diabetic foot
Pomposelli, F. B. (2000) · Journal of Vascular Surgery · doi:10.1067/mva.2000.108836 · Cited by 67
Acker, K. V., Oleen-Burkey, M. A., de Decker, L., Vanmaele, R., Schil, P. E. V., Matricali, G. A., Dys, H., & Leeuw, I. D. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00157-1 · Cited by 63
Ghatnekar, O., Persson, U., Willis, M. S., & Ödegaard, K. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119070-00005 · Cited by 57
Cost of diabetes-related amputations in minorities
Ashry, H. R., Lavery, L. A., Armstrong, D. G., Lavery, D. C., & van Houtum, W. H. (1998) · The Journal of Foot & Ankle Surgery · doi:10.1016/s1067-2516(98)80108-7 · Cited by 52
Persson, U., Willis, M. S., Ödegaard, K., & Apelqvist, J. (2000) · Value in Health · doi:10.1046/j.1524-4733.2000.36027.x · Cited by 47
Self-citationHospital In‐patient Statistics Underestimate the Morbidity Associated with Diabetes Mellitus
Leslie, P. J., Patrick, A. W., Hepburn, D. A., Scougal, I. J., & Frier, B. M. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01801.x · Cited by 43
Tennvall, G. R., Apelqvist, J., & Eneroth, M. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00748.x · Cited by 39
Self-citation
Cited by
Preventing Foot Ulcers in Patients With Diabetes
Singh, N. (2005) · JAMA · doi:10.1001/jama.293.2.217 · Cited by 3,097
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566
Self-citationGlobal epidemiology of diabetic foot ulceration: a systematic review and meta-analysis
Zhang, P., Lu, J., Jing, Y., Tang, S., Zhu, D., & Bi, Y. (2017) · Annals of Medicine · doi:10.1080/07853890.2016.1231932 · Cited by 1,853
Prompers, L., Huijberts, M., Apelqvist, J., Jude, E., Piaggesi, A., Bakker, K., Edmonds, M., Holstein, P., Jirkovska, A., Mauricio, D., et al. (2007) · Diabetologia · doi:10.1007/s00125-006-0491-1 · Cited by 1,023
Self-citationPrompers, L., Schaper, N., Apelqvist, J., Edmonds, M., Jude, E., Mauricio, D., Uccioli, L., Urbancic, V., Bakker, K., Holstein, P., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-0940-0 · Cited by 1,019
Self-citation
Metadata
- Authors
- Ragnarson Tennvall, G., & Apelqvist, J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-01
- Volume
- 39
- Issue
- Supplement_2
- Pages
- S132-S139
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2138509561
- Cited by
- 303
- References
- 38
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.